How do you treat colorectal cancer with heterogeneous loss of mismatch repair protein expression?  

My approach, broadly, for stage IV (nonsurgical) patients is to try to treat with IO agents, and then address tumors that may not be responding (SBRT, ablation, etc) down the road (presumably those that aren't as sensitive to IO). The other option would be to use something like FOLFOX+checkpoint inh...